Veritas Strikes Again! AstraZeneca TOP DOG – ‘Millions of [Immunocompromised] People Can’t Be Vaccinated’

Big Pharma head also admits, ‘Antibody [treatment] offers enormous potential’

Project Veritas released a never-before-heard recording on Tuesday where AstraZeneca CEO Pascal Soriot admitted throughout a December 2020 Zoom contact that many immunocompromised individuals shouldn’t have received the company’s Covid vaccine.

“ If you have an immune disease, lupus or some other immune system condition, you cannot – or multiple sclerosis, you can’t be vaccinated, ” Soriot states in the clip. “ Therefore , there are millions of people in the world that will need a protection that cannot be coming from a vaccine. ”

The CEO in fact promoted monoclonal antibodies during the time, telling his staff, “ The longer antibody has enormous potential. ”

Continuing to describe the monoclonal antibodies, Soriot said, “ The particular long-acting antibody is quite unique because this is the only combination potentially will last more than 6 months, up to potentially 12 months plus protect people for a long period of your time. ”

As Project Veritas founder Adam O’Keefe notes in the video clip, monoclonal antibodies were known to be effective against Covid-19 early in the pandemic.

However , the Biden administration made it difficult for states like Texas and California to obtain the treatment at the elevation of its demand so vaccines would be promoted instead.

Despite the company’s TOP DOG acknowledging the shot is dangerous for certain people, the World Health Organization currently maintains, “ the full two dosage regimen of” the AstraZeneca vaccine is recommended.

In fact , the WHO advisory says, “ SAGE [Strategic Advisory Group of Experts on Immunization] recommends that severe and moderately immunocompromised persons should be offered an extra dose of vaccine. ”

According to the Big Pharma CEO, the WHO is basically telling those who are at a higher risk of having an adverse reaction that they need to take an extra dose from the experimental jabs.


Leave a Reply

Your email address will not be published. Required fields are marked *